Alkem Laboratories' debut in stock markets has been nothing short of phenomenal, with its shares gaining 47 per cent in two trading sessions.
Alkem Lab gets 75 per cent of its revenue from domestic markets. 25 per cent revenue comes from global markets, predominantly US, which contributes close to 90 per cent of Alkem Lab's international revenue.
"We went from $10 million to $100 million in US in 5 years and want to grow further aggressively. In the next couple of years we plan to launch 5-10 products in US," said Sandeep Singh, joint MD of Alkem Lab.
To achieve that (US growth) we have increased the spend on research and development to close to 5 per cent of our revenue from earlier 2.5 per cent five years back, he said.
Mr Singh told NDTV Profit that Alkem Lab's business has been built over 40 years without any debt and private equity.
"Going ahead we will focus to continue doing that," he added.
Alkem Laboratories' debut in stock markets has been nothing short of phenomenal, with its shares gaining 47 per cent in two trading sessions.
Alkem Lab gets 75 per cent of its revenue from domestic markets. 25 per cent revenue comes from global markets, predominantly US, which contributes close to 90 per cent of Alkem Lab's international revenue.
"We went from $10 million to $100 million in US in 5 years and want to grow further aggressively. In the next couple of years we plan to launch 5-10 products in US," said Sandeep Singh, joint MD of Alkem Lab.
To achieve that (US growth) we have increased the spend on research and development to close to 5 per cent of our revenue from earlier 2.5 per cent five years back, he said.
Mr Singh told NDTV Profit that Alkem Lab's business has been built over 40 years without any debt and private equity.
"Going ahead we will focus to continue doing that," he added.
Alkem Laboratories' debut in stock markets has been nothing short of phenomenal, with its shares gaining 47 per cent in two trading sessions.
Alkem Lab gets 75 per cent of its revenue from domestic markets. 25 per cent revenue comes from global markets, predominantly US, which contributes close to 90 per cent of Alkem Lab's international revenue.
"We went from $10 million to $100 million in US in 5 years and want to grow further aggressively. In the next couple of years we plan to launch 5-10 products in US," said Sandeep Singh, joint MD of Alkem Lab.
To achieve that (US growth) we have increased the spend on research and development to close to 5 per cent of our revenue from earlier 2.5 per cent five years back, he said.
Mr Singh told NDTV Profit that Alkem Lab's business has been built over 40 years without any debt and private equity.
"Going ahead we will focus to continue doing that," he added.
Sign Up with Google
RECOMMENDED FOR YOU
POPULAR